149 related articles for article (PubMed ID: 10431795)
1. Anticardiolipin antibodies and occlusive vascular disease of the eye: prospective study.
Kalogeropoulos CD; Spyrou P; Stefaniotou MI; Tsironi EE; Drosos AA; Psilas KG
Doc Ophthalmol; 1998; 95(2):109-20. PubMed ID: 10431795
[TBL] [Abstract][Full Text] [Related]
2. [Anticardiolipin antibodies in vascular occlusions of the eye].
Bertram B; Haase G; Remky A; Reim M
Ophthalmologe; 1994 Dec; 91(6):768-71. PubMed ID: 7849429
[TBL] [Abstract][Full Text] [Related]
3. Antiphospholipid antibodies in ocular arterial and venous occlusive disease.
Palmowski-Wolfe AM; Denninger E; Geisel J; Pindur G; Ruprecht KW
Ophthalmologica; 2007; 221(1):41-6. PubMed ID: 17183200
[TBL] [Abstract][Full Text] [Related]
4. Antiphospholipid antibodies and retinal thrombosis in patients without risk factors: a prospective case-control study.
Cobo-Soriano R; Sánchez-Ramón S; Aparicio MJ; Teijeiro MA; Vidal P; Suárez-Leoz M; Rodriguez-Mahou M; Rodriguez-Huerta A; Fernández-Cruz E; Cortés C
Am J Ophthalmol; 1999 Dec; 128(6):725-32. PubMed ID: 10612509
[TBL] [Abstract][Full Text] [Related]
5. The role of IgM isotype anticardiolipin antibodies in occlusive ocular vascular disease: report of two cases with primary antiphospholipid antibody syndrome.
Dogulu CF; Kansu T; Kadayifcilar S
Eye (Lond); 2000 Oct; 14 Pt 5():789-90. PubMed ID: 11116709
[No Abstract] [Full Text] [Related]
6. The role of IgM isotype anticardiolipin antibodies in ocular vaso-occlusive disease.
Puri P; Squirrell D
Eye (Lond); 2001 Jun; 15(Pt 3):365. PubMed ID: 11450756
[No Abstract] [Full Text] [Related]
7. Ocular involvement in primary antiphospholipid syndrome. Ocular involvement in primary APS.
Demirci FY; Küçükkaya R; Akarçay K; Kir N; Atamer T; Demirci H; Ongör E
Int Ophthalmol; 1998; 22(6):323-9. PubMed ID: 10937845
[TBL] [Abstract][Full Text] [Related]
8. Amaurosis fugax in ocular vascular occlusive disorders: prevalence and pathogeneses.
Hayreh SS; Zimmerman MB
Retina; 2014 Jan; 34(1):115-22. PubMed ID: 23632956
[TBL] [Abstract][Full Text] [Related]
9. Antiphospholipid antibodies in retinal vascular occlusions. A prospective study of 75 patients.
Glacet-Bernard A; Bayani N; Chretien P; Cochard C; Lelong F; Coscas G
Arch Ophthalmol; 1994 Jun; 112(6):790-5. PubMed ID: 8002838
[TBL] [Abstract][Full Text] [Related]
10. [Retinal vein occlusion followed by ischemic optic neuropathy with anticardiolipin IgG antibody: a case report].
Yamamoto T; Mimura O; Kawasaki T; Ideta R; Ideta H
Nippon Ganka Gakkai Zasshi; 2009 Oct; 113(10):972-9. PubMed ID: 19882933
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Dilemma in Sequential Branch Retinal Vein and Artery Occlusion.
Consigli A; Roquelaure D; Souteyrand G; Chizzolini C; Thumann G; Chronopoulos A
Optom Vis Sci; 2015 Nov; 92(11):e404-8. PubMed ID: 26421682
[TBL] [Abstract][Full Text] [Related]
12. Anticardiolipin IgG antibody and homocysteine as possible risk factors for retinal vascular occlusive disease in thai patients.
Atchaneeyasakul LO; Trinavarat A; Bumrungsuk P; Wongsawad W
Jpn J Ophthalmol; 2005; 49(3):211-5. PubMed ID: 15944825
[TBL] [Abstract][Full Text] [Related]
13. Cilioretinal artery occlusion: an ocular complication of primary antiphospholipid syndrome.
Dori D; Gelfand YA; Brenner B; Miller B
Retina; 1997; 17(6):555-7. PubMed ID: 9428022
[No Abstract] [Full Text] [Related]
14. Anticardiolipin antibodies in Adamantiades-Behçet's disease.
Zouboulis CC; Büttner P; Tebbe B; Orfanos CE
Br J Dermatol; 1993 Mar; 128(3):281-4. PubMed ID: 8471511
[TBL] [Abstract][Full Text] [Related]
15. [Role of antiphospholipid antibodies in occlusion of retinal vessels in various vascular eye diseases].
Ermakova NA; Alekberova ZS; Nasonov EL; Kosheleva NM; Reshetniak TM; Aleksandrova EN
Vestn Oftalmol; 2002; 118(2):29-32. PubMed ID: 12096532
[TBL] [Abstract][Full Text] [Related]
16. Ocular features associated with anticardiolipin antibodies: a descriptive study.
Miserocchi E; Baltatzis S; Foster CS
Am J Ophthalmol; 2001 Apr; 131(4):451-6. PubMed ID: 11292408
[TBL] [Abstract][Full Text] [Related]
17. Elevated anticardiolipin antibody titer is a stroke risk factor in a multiethnic population independent of isotype or degree of positivity.
Tuhrim S; Rand JH; Wu XX; Weinberger J; Horowitz DR; Goldman ME; Godbold JH
Stroke; 1999 Aug; 30(8):1561-5. PubMed ID: 10436101
[TBL] [Abstract][Full Text] [Related]
18. Anticardiolipin antibodies in patients with type 2 diabetes mellitus.
Calvo-Romero JM; Lima-Rodríguez EM
Clin Med Res; 2009 Sep; 7(3):93-5. PubMed ID: 19251581
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous bilateral central retinal vein occlusion associated with anticardiolipin antibodies in leukemia.
Al-Abdulla NA; Thompson JT; LaBorwit SE
Am J Ophthalmol; 2001 Aug; 132(2):266-8. PubMed ID: 11476696
[TBL] [Abstract][Full Text] [Related]
20. SERUM LEVELS OF ANTIBODIES AGAINST OXIDATION-SPECIFIC EPITOPES ARE DECREASED IN PATIENTS WITH RETINAL VEIN OCCLUSION.
Posch-Pertl L; Weger M; Pinter-Hausberger S; List W; Posch F; Wedrich A; Michelitsch K; Kozma MO; Woltsche N; Binder CJ
Retina; 2021 Jun; 41(6):1193-1201. PubMed ID: 33136978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
